Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of “Hold” by Analysts

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) has been given a consensus rating of “Hold” by the twenty-one analysts that are currently covering the stock, Marketbeat reports. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $12.08.

Several brokerages have recently commented on TDOC. Evercore ISI boosted their price objective on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Piper Sandler reissued an “overweight” rating and issued a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Barclays increased their target price on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Finally, TD Cowen dropped their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research note on Thursday, October 31st.

View Our Latest Analysis on TDOC

Insider Buying and Selling

In other news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.95% of the stock is owned by insiders.

Institutional Trading of Teladoc Health

A number of institutional investors and hedge funds have recently bought and sold shares of TDOC. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Teladoc Health during the fourth quarter valued at approximately $272,000. Rhumbline Advisers increased its holdings in shares of Teladoc Health by 1.8% in the 4th quarter. Rhumbline Advisers now owns 281,420 shares of the health services provider’s stock worth $2,558,000 after purchasing an additional 5,018 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in shares of Teladoc Health in the fourth quarter worth $2,859,000. Summit Trail Advisors LLC purchased a new stake in shares of Teladoc Health during the fourth quarter valued at $92,000. Finally, Murphy Pohlad Asset Management LLC bought a new stake in Teladoc Health in the 4th quarter worth about $458,000. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Down 1.8 %

Shares of NYSE:TDOC opened at $10.16 on Monday. The firm has a fifty day moving average price of $10.08 and a two-hundred day moving average price of $9.08. The company has a market cap of $1.75 billion, a price-to-earnings ratio of -1.76 and a beta of 1.01. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a one year low of $6.76 and a one year high of $21.74.

Teladoc Health (NYSE:TDOCGet Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Analysts anticipate that Teladoc Health will post -1.16 EPS for the current fiscal year.

Teladoc Health Company Profile

(Get Free Report

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Articles

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.